Cargando…
Permanent diabetes insipidus in a patient with mesothelioma treated with immunotherapy
Checkpoint inhibitors have substantially improved the prognosis for patients with advanced malignancy. Treatment with immunomodulants has the ability to reactivate the immune system against tumor cells, but can also trigger the development of immune-related adverse events that reflects a loss of tol...
Autores principales: | Brilli, Lucia, Calabrò, Luana, Campanile, Michele, Pilli, Tania, Agostinis, Cristina, Cerase, Alfonso, Maio, Michele, Castagna, Maria Grazia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522091/ https://www.ncbi.nlm.nih.gov/pubmed/32267349 http://dx.doi.org/10.20945/2359-3997000000221 |
Ejemplares similares
-
CONUT Score: A New Tool for Predicting Prognosis in Patients with Advanced Thyroid Cancer Treated with TKI
por: Dalmiglio, Cristina, et al.
Publicado: (2022) -
Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy
por: Brilli, L., et al.
Publicado: (2020) -
Immune checkpoint blockade in malignant mesothelioma: A novel therapeutic strategy against a deadly disease?
por: Calabrò, Luana, et al.
Publicado: (2014) -
Immunotherapy of brain metastases: breaking a “dogma”
por: Di Giacomo, Anna Maria, et al.
Publicado: (2019) -
Improvement of Overall Survival Using TKIs as Salvage Therapy in Advanced Thyroid Carcinoma: Real-Life Data on a Single Center Experience
por: Brilli, Lucia, et al.
Publicado: (2021)